Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CIDOFOVIR vs CILGAVIMAB\TIXAGEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CIDOFOVIR vs CILGAVIMAB\TIXAGEVIMAB: Safety Overview

Metric CIDOFOVIR CILGAVIMAB\TIXAGEVIMAB
Total FAERS Reports 715 2,168
Deaths Reported 165 359
Death Rate 23.1% 16.6%
Hospitalizations 238 998
Average Patient Age 34.7 yrs 62.2 yrs
% Female Patients 50.1% 47.6%
FDA Approval Date Jul 26, 2012 N/A
Manufacturer Mylan Institutional LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A